TYKERB 250 MG 70 TB

Tykerb (lapatinib) is a medication used in the treatment of HER2-positive breast cancer, particularly when the cancer has spread to other parts of the body (metastatic breast cancer). The formulation you mentioned, Tykerb 250 mg tablets, contains lapatinib as the active ingredient. Each tablet typically contains 250 mg of lapatinib. Lapatinib is classified as a tyrosine kinase inhibitor. It works by blocking the action of specific proteins (tyrosine kinases) that are involved in the growth and spread of cancer cells, particularly those associated with HER2-positive breast cancer. By inhibiting these proteins, lapatinib helps to slow down or stop the growth of cancer cells, thereby aiding in the treatment of metastatic breast cancer. It’s important to take Tykerb exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer, your overall health, and other medications you may be taking. Always follow your doctor’s instructions carefully and report any side effects or concerns promptly.